Last Week’s Top 3 Most Read Posts On Pulmonary Fibrosis
Read the articles here:Â
1. Potential Therapy for IPF and Fatty Liver Disorders Shows Safety in Early Clinical Trial
2. Systemic Sclerosis Patients with ILD Being Asked to Participate in Phase 3 Study of OFEV
3. In PF Mice, Fibroblast Activation Protein Seen to Speed Collagen Clearance from Lungs